LICENSE AGREEMENTLicense Agreement • July 19th, 2004 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • New York
The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***.
Dated July 14, 2004 US$50,000,000 LOAN AGREEMENT BETWEEN VERNALIS PLC as Parent VERNALIS DEVELOPMENT LIMITED as Borrower and ENDO PHARMACEUTICALS INC. as Lender Skadden, Arps, Slate, Meagher & Flom LLP 4 Times Square New York, NY 10036Security Deed • July 19th, 2004 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations • New York
This SECURITY DEED, dated as of July , 2004 (this “Security Deed”), between VERNALIS DEVELOPMENT LIMITED, a limited liability company incorporated under the laws of England and Wales with company number 2600483 and with a registered address at Oakdene Court, 613 Reading Road, Winnersh, Workingham, Berkshire, RG41 5UA, as the grantor (the “Grantor”), and ENDO PHARMACEUTICALS INC., a Delaware corporation, as the secured party (the “Secured Party”).
